4BASEBIO PLC - Investor Presentation

In this episode, we examine 4BASEBIO PLC's innovative approach to DNA manufacturing, which could transform genetic medicine. Traditional methods rely on bacterial fermentation, raising concerns about contamination with bacterial DNA. 4BASEBIO offers a self-free solution using proprietary enzymes, enhancing purity and efficiency in DNA production. This technology not only reduces the manufacturing footprint but also significantly shortens timelines for clinical applications. However, despite the technical advancements, market realities like consumer trust and sentiment still play a crucial role in the success of biotech innovations.